Showing results (171-180 of 207) with videos related to
Sort By:
Pageof 21
Plos One|April 27, 2013
Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent mannersRive Sarfstein, Yael Friedman, Zohar Attias-Geva, et al.Journal of Molecular Neuroscience : MN|March 5, 2004
Modulation of brain insulin-like growth factor I (IGF-I) binding sites and hypothalamic GHRH and somatostatin levels by exogenous growth hormone and IGF-I in juvenile ratsRina Eshet, Irit Gil-Ad, Olga Apelboym, et al.Molecular and Cellular Endocrinology|April 27, 2010
Differential regulation of insulin-like growth factor-I receptor gene expression by wild type and mutant androgen receptor in prostate cancer cellsHagit Schayek, Hila Seti, Norman M Greenberg, et al.Harefuah|January 22, 2019
[THE PROLIFERATIVE EFFECT OF DENDRITIC CELLS IN OVARIAN CANCER AND THE RELATIONSHIP WITH THE IGF SIGNALING PATHWAY]Muna Alemi Yahya, Shilhav Meisel Sharon, Shay Hantisteanu, et al.European Journal of Cancer (Oxford, England : 1990)|March 26, 2010
HMGA1 protein is a positive regulator of the insulin-like growth factor-I receptor geneAurora Aiello, Giuseppe Pandini, Rive Sarfstein, et al.Endocrinology|May 8, 2004
Transcriptional activation of the insulin-like growth factor I receptor gene by the Kruppel-like factor 6 (KLF6) tumor suppressor protein: potential interactions between KLF6 and p53Moran Rubinstein, Gila Idelman, Stephen R Plymate, et al.Cancer Letters|May 30, 2006
A novel EWS-WT1 gene fusion product in desmoplastic small round cell tumor is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) geneHaim Werner, Gila Idelman, Moran Rubinstein, et al.European Journal of Cancer (Oxford, England : 1990)|April 1, 2011
Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cellsZohar Attias-Geva, Itay Bentov, Dale L Ludwig, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 14, 2017
Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone MassZhongbo Liu, Tianzhen Han, Haim Werner, et al.Oncotarget|May 12, 2020
Proteomic analysis of combined IGF1 receptor targeted therapy and chemotherapy identifies signatures associated with survival in breast cancer patientsTali Sinai-Livne, Metsada Pasmanik-Chor, Zoya Cohen, et al.Pageof 21